Allergies News and Research

Latest Allergies News and Research

UIC clinical trial to soon test a vaccine for COVID-19

The University of Illinois at Chicago will soon test a vaccine for COVID-19.

15 Jun 2020

DeNovix Pink CellDrop™ automated cell counter giveaway won by University of Pittsburgh

DeNovix Inc. is pleased to announce that the winner of their recent competition to receive a donation of a unique, pink CellDrop Automated Cell Counter is Beth Kahkonen, from the University of Pittsburgh, USA. Selected at random from thousands of entries from scientists worldwide, the CellDrop will be housed in the University’s Division of Pulmonary, Allergy, and Critical Care Medicine.

From DeNovix Inc. 15 Jun 2020

NIAID and Moderna scientists describe SARS-CoV-2 vaccine development

Researchers at the National Institute of Allergy and Infectious Diseases and Moderna Inc., have described the potent neutralizing effects of a candidate vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is currently being tested in a phase II trial.

14 Jun 2020

Study shows how combining two drugs may be an effective treatment for HLH

Scientists at St. Jude Children's Research Hospital, UCSF Benioff Children's Hospitals and Baylor College of Medicine are investigating how to best treat hemophagocytic lymphohistiocytosis (HLH), a rare immune disorder.

12 Jun 2020

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.

12 Jun 2020

Immune modulation can cure severe and often fatal fungal infection in children

In the June 11 issue of the New England Journal of Medicine, a team of UCLA physicians and scientists describes the first case of immune modulation being used to cure a severe and often fatal fungal infection.

11 Jun 2020

Key enzyme that contributes to eczema identified

Researchers at the University of British Columbia (UBC) and Vancouver Coastal Health Research Institute have identified a key enzyme that contributes to eczema, which may lead to better treatment to prevent the skin disorder's debilitating effects.

10 Jun 2020

UVA Health increasing access to food allergy clinical trials and expanding research

UVA Health and UVA Children's are increasing access to the latest food allergy clinical trials and expanding their cutting-edge food-allergy research, following their selection to a national food-allergy clinical network.

10 Jun 2020

Old antibiotic may be a powerful new tool against deadly superbug

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body.

8 Jun 2020

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Dr. Leszek Ignatowicz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $1.95 million federal grant to study what causes autoimmunity in the human body.

8 Jun 2020

Actual mortality rate of COVID-19-affected adults is less than what was previously reported

An online first study published in Critical Care Medicine indicates the actual mortality rate of adults with critical illness from COVID-19 is less than what was previously reported.

5 Jun 2020

Study: Eggs can be used as low-cost coating to protect fruits and vegetables

Eggs that would otherwise be wasted can be used as the base of an inexpensive coating to protect fruits and vegetables, according to Rice University researchers.

5 Jun 2020

Next-generation sequencing of COVID-19 virus offers powerful metagenomic data

Next-generation sequencing of the COVID-19 virus is providing powerful metagenomic data, which, combined with clinical data, will inform the search for effective treatments, as reported in the peer-reviewed journal Pediatric Allergy, Immunology, and Pulmonology.

4 Jun 2020

Assessing the integrity of remdesivir clinical trial during COVID-19 pandemic

As acknowledged in the first remdesivir double-blind placebo-controlled clinical trial addressing treatment for COVID-19 recently published in Lancet (Wang, et al., April 29, 2020), a statistician at Rutgers Cancer Institute of New Jersey was called on to guard the integrity of that trial.

4 Jun 2020

New research focuses on protein-coding gene's role in inflammatory bowel disease

A protein-coding gene associated with autoimmune diseases such as Crohn's disease and ulcerative colitis, collectively referred to as inflammatory bowel disease, or IBD, will be the focus of new research in the School of Medicine at the University of California, Riverside.

4 Jun 2020

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Eli Lilly and Company today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight COVID-19.

4 Jun 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Allergies News and Research

Latest Allergies News and Research

UIC clinical trial to soon test a vaccine for COVID-19

DeNovix Pink CellDrop™ automated cell counter giveaway won by University of Pittsburgh

NIAID and Moderna scientists describe SARS-CoV-2 vaccine development

Study shows how combining two drugs may be an effective treatment for HLH

Texas Heart Institute and 7 Hills Pharma receive $1.9 million to improve stem cell transplants

Immune modulation can cure severe and often fatal fungal infection in children

Key enzyme that contributes to eczema identified

UVA Health increasing access to food allergy clinical trials and expanding research

Old antibiotic may be a powerful new tool against deadly superbug

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Actual mortality rate of COVID-19-affected adults is less than what was previously reported

Study: Eggs can be used as low-cost coating to protect fruits and vegetables

Next-generation sequencing of COVID-19 virus offers powerful metagenomic data

Assessing the integrity of remdesivir clinical trial during COVID-19 pandemic

New research focuses on protein-coding gene's role in inflammatory bowel disease

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

New drug can prevent life-threatening anaphylaxis, shows study

Bacteria that live in soil and on people have extensive antibiotic-destroying genes

Rigidity of tissues drives immune system activity, UCLA study finds

A new tool to help biomedical scientists better understand COVID-19 virus

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in